Towards Healthcare
Controlled Substance Market to Drive USD 157.7 Bn by 2034

Controlled Substance Market 2025 Future Shaped by Policy and Tech

Market insights predict the global controlled substance industry will increase from USD 93.7 billion in 2024 to USD 157.7 billion by 2034, achieving a CAGR of 5.35%. The rising prevalence of chronic and neurological disorders is estimated to drive the growth of the market. North America led the global market owing to the advanced healthcare infrastructure and major key players in the region.

Content

  • Insight Code: 6159
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: September 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Shivani Zoting is a dedicated research analyst specializing in the healthcare industry. With a strong academic foundation, a B.Sc. in Biotechnology and an MBA in Pharmabiotechnology, she brings a unique blend of scientific understanding and market strategy to her research.

Shivani contributes to Towards Healthcare and plays an active role at Precedence Research, where she focuses on delivering in-depth market intelligence, competitive analysis, and trend forecasting across pharmaceuticals, medical devices, digital health, and healthcare services. Her insights support healthcare companies, investors, and policymakers in making data-backed decisions in a highly regulated and rapidly evolving sector.

Additionally, Shivani collaborates with Statifacts, further expanding her healthcare domain reach by engaging in diverse projects across global markets. Her strength lies in transforming complex clinical and commercial data into strategic narratives that help stakeholders navigate the future of healthcare.

Talk to us
FAQ's

The controlled substance market currently in 2025 records USD 98.71 billion and is anticipated to grow to USD 157.7 billion by 2034, advancing at a CAGR of 5.35% from 2024 to 2034.

North America is leading the controlled substance market due to the growing demand for neurological disorders, advancements in therapy, and the presence of key players.

The controlled substance market includes eight segments including by cytokine type, by application, by source, by host expression system, by end-user, by formulation, by packaging size, and by region.

Key trends include the growing regulatory and legal pressure, policy reforms, and adoption of inorganic growth strategies.

Opioids remain a central category, widely prescribed for pain management. However, due to risks of addiction, regulators are tightening controls, driving demand for safer formulations and alternatives.

National Association of Boards of Pharmacy (NABP), Personalized Medicine Coalition, National Association of State Controlled Substances Authorities, Government of Canada, International Narcotics Control Board (INCB), Food and Drug Administration, clinicaltrials.gov, U.S. Department of Justice Drug Enforcement Administration-Diversion Control Division, GOV.UK.
Any Questions